4 Results for "

Relugolix

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "Relugolix" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-16474
CAS No.: 737789-87-6
Synonyms: TAK-385
Target:  

GnRH Receptor

Research Areas:  

Endocrinology Cancer

Relugolix (TAK-385)?is a potent, orally active, nonpeptidic gonadotropin-releasing hormone (GnRH) antagonist. Relugolix possesses high affinity and potent antagonistic activity for human receptor (binding IC50=0.33 nM) and monkey receptor (IC50=0.32 nM) compared with TAK-013 (HY-100209) . Relugolix is used for the study of sex-hormone-dependent diseases, such as including endometriosis, uterine fibroids and prostate cancer et al .
loading...
    loading...
Cat. No.: HY-16474R
CAS No.: 737789-87-6
Synonyms: TAK-385 (Standard)
Research Areas:  

Endocrinology Cancer

Relugolix (Standard) is the analytical standard of Relugolix. This product is intended for research and analytical applications. Relugolix (TAK-385) is a potent, orally active, nonpeptidic gonadotropin-releasing hormone (GnRH) antagonist. Relugolix possesses high affinity and potent antagonistic activity for human receptor (binding IC50=0.33 nM) and monkey receptor (IC50=0.32 nM) compared with TAK-013 (HY-100209) . Relugolix is used for the study of sex-hormone-dependent diseases, such as including endometriosis, uterine fibroids and prostate cancer et al .
loading...
    loading...
Cat. No.: HY-16474S
Synonyms: TAK-385-d6
Relugolix-d6 is deuterium labeled Relugolix. Relugolix (TAK-385)?is a potent, orally active, nonpeptidic gonadotropin-releasing hormone (GnRH) antagonist. Relugolix possesses high affinity and potent antagonistic activity for human receptor (binding IC50=0.33 nM) and monkey receptor (IC50=0.32 nM) compared with TAK-013 (HY-100209) . Relugolix is used for the study of sex-hormone-dependent diseases, such as including endometriosis, uterine fibroids and prostate cancer et al .
loading...
    loading...
Cat. No.: HY-151247
CAS No.: 2826273-90-7
Target:  

GnRH Receptor

Research Areas:  

Cancer

GnRH-R antagonist 1 (compound 21a) is an orally safe and membrane-permeable GnRH-R antagonist with high binding affinity (IC50=0.57 nM) and potent in vitro antagonistic activity (IC50=2.18 nM). GnRH-R antagonist 1 can be used in studies of advanced prostate cancer and premature LH peaks preventing .
loading...
    loading...